A recent five-month study revealed a common over-the-counter antihistamine, clemastine fumarate, “partially reversed damage to the visual system in people with multiple sclerosis (MS) in a preliminary study.” (ScienceDaily) Fifty participants in the five-month study averaged 40 years of age and were not recently recovering from an optic neuritis attack but did have “stable chronic optic neuropathy.”
“This study is exciting because it is the first to demonstrate possible repair of that protective coating in people with chronic demyelination from MS,” said Ari Green, study author. The reversal in the short study was modest but exciting none-the-less. Good news for me given my vision deficits.
For further information read:
Image from www.msunites.com.